Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 18

1469P - Development of an efficacy prediction model for concurrent chemoradiotherapy in esophageal squamous cell carcinoma using deep learning and multimodal data integration

Date

14 Sep 2024

Session

Poster session 18

Topics

Radiation Oncology

Tumour Site

Presenters

Xin Yang

Citation

Annals of Oncology (2024) 35 (suppl_2): S878-S912. 10.1016/annonc/annonc1603

Authors

X. Yang1, J. Liu2, B. Feng3, F. Jin4

Author affiliations

  • 1 Radiation Physics Center, Chongqing University Cancer Hospital, 400030 - Chongqing/CN
  • 2 Department Of Oncology, Mianyang Central Hospital, 621000 - Mianyang/CN
  • 3 Radiation Physics Center, Chongqing Cancer Hospital, 400030 - Chongqing/CN
  • 4 Chongqing University Cancer Hospital, Chongqing Cancer Hospital, 400000 - Chongqing/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1469P

Background

Employing deep learning techniques, this study aims to construct a dual-center predictive model for evaluating the efficacy of concurrent chemoradiotherapy in esophageal squamous cell carcinoma. Through the amalgamation of pre-treatment CT images, clinical features, dosimetric parameters, radiomic features, and 3D dose distribution data, a comprehensive dataset was assembled. Extensive patient data collection facilitated the development of a sophisticated efficacy prediction model using deep learning algorithms.

Methods

Between 2018.01- 2022.11, data from 369 esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy at 2 medical centers were retrospectively analyzed. Dosimetric factors, including average and maximum doses for PTV, were derived from DVH. Clinical features such as gender, age, smoking and alcohol history, and clinical staging were also extracted. A total of 1349 radiomic features were extracted, and cluster analysis was utilized to identify radiomic features correlated with treatment efficacy. The deep learning algorithm was subjected to end-to-end training, amalgamating multiple data sources to establish a complex predictive model.

Results

In cluster analysis, a total of 112 highly correlated radiomic features were identified for further investigation. The model exhibited promising performance metrics on the validation set, with an accuracy of 0.802, sensitivity of 0.801 (95% CI [0.245, 0.987]), and specificity of 0.818 (95% CI [0.359, 0.995]). During five-fold cross-validation, the AUC ranged between 0.83 and 0.93, indicating robustness across multiple iterations of model evaluation.

Conclusions

This study introduces a comprehensive approach, leveraging deep learning techniques to integrate diverse data sources for predicting concurrent chemoradiotherapy efficacy in esophageal squamous cell carcinoma. The model not only demonstrates exceptional predictive accuracy but also pioneers the exploration of 3D dose distribution significance, offering novel insights for tailored treatment strategies.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.